tirzepatide versus semaglutide once weekly Item - in Patients with Type 2 Diabetes - University of Leicester Tirzepatide vs. Semaglutide: What's the
Description
Clinical trials have shown HbA1c reductions of up to 2.4% and body weight losses of up to 22.5%, with improvements in insulin sensitivity, lipid metabolism, and cardiometabolic markers 2,3
supervision, A.J
Choosing between tirzepatide and semaglutide depends on your goals, tolerability, and coverage landscape
The 68-week STEP 1 trial showed 14.9% mean body weight reduction at 2.4mg, compared to retatrutide hitting 17.5% at just 24 weeks with the 12mg dose
